Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Ocera Therapeutics (NASDAQ: OCRX)

$1.30 USD -$0.03 (-2.26%)
Last Price $1.3
Net Change $-0.03 (-2.26%)
Bid $1.18
Ask Price $1.75
Open Price $1.32
Previous Close Price $1.33
High Price $1.37
Low Price $1.3
Number of Trades 603
Volume 341,300
Fifty Two Week High $3.27 (2016-04-22)
Fifty Two Week Low $0.52 (2017-02-07)
Average Daily Volume 2,674,416
Share Outstanding 23,600 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $24.32
Recent Earnings $
Annual EPS $-1.23
Last Quarter EPS $
Market Capitalization $0.03B
Insider Shareholders % 0.061%
Annual Revenue $0B
No. Shares Outstanding 23,600
Inst. Shareholder % 38.8%
Annual Net Income $0B
TTM Net Profit Margin $100.2
1-Year Return -57.1%
3-Year Return -85.7%
5-Year Return -96.54%
5-Year Revenue Growth -94%
5-Year Earnings Growth -91.67%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 24.32%
Dividends per Share $
Stock Split Ratio 1-12
Beta 2.1
Ocera Therapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver diseases. Ocera Therapeutics, Inc., formerly known as Tranzyme, Inc., is based in San Diego, California.